Recent years have seen growing interest in the use of artificial intelligence tools for healthcare applications, including diagnosis, risk prediction,…
Durham-based BioSkryb Genomics, a developer of advanced molecular tools for single-cell analysis, has signed a multi-year agreement with Cooper Genomics to…